Prothena Corporation plc
PRTA • NASDAQ
Prothena Corporation plc is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gene G. Kinney, with a market cap of $574.4M.
Market Cap$574.4M
Employees173.0
CEOGene G. Kinney
CountryIreland
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 3 weeksAfter Market Close · Q1 2026
Financials
Prothena Corporation plc FAQ
Common questions about Prothena Corporation plc
Prothena Corporation plc is scheduled to report earnings for Q1 2026 on May 14, 2026 after market close. Analysts estimate revenue of $808.9K.
Prothena Corporation plc has approximately 173 employees.